SCRI: MM165: Ph2 TECVAYLI in multiple myeloma patients ( IIT MM165)

Phase II Clinical Trial

64007957MMY2010/MM165: Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma (OPTec/OPTal)

Trial Number: 05972135
Trial Status: Call Proj Mgr

Learn more about this clinical trial.

Participating Locations